Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of TRC101 in Subjects With Chronic Kidney Disease and Low Serum Bicarbonate Levels

NCT02809183 is registered in ClinicalTrials.gov with Tricida, Inc. as lead sponsor.

NCT NCT02809183
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02809183 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of TRC101 in Subjects With Chronic Kidney Disease and Low Serum Bicarbonate Levels
Lead sponsor
Tricida, Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
March 31, 2016
Completion date
November 30, 2016
Enrollment
135 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

acidosis